KYMR
Kymera Therapeutics, Inc. · Healthcare · Biotechnology
Momentum-Eingaben (vergleichbare Manager):
Halterbreite +9.1% ·
Aktienfluss +5.7% ·
neue Nettopositionen +8.3%
— Formel
Breite Akkumulation — steigende Anteile bei mehr Haltern
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q4 2024
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 101 | +12 | 52.72M | $6.01B | +14 | −1 |
| Q1 2026 | 91 | -4 | 48.20M | $4.01B | +6 | −11 |
| Q4 2025 | 94 | 0 | 48.74M | $3.79B | +1 | — |
| Q3 2025 | 17 | 0 | 32.08M | $1.82B | — | −1 |
| Q2 2025 | 15 | +3 | 31.72M | $1.38B | +3 | — |
| Q1 2025 | 9 | -3 | 16.51M | $451.78M | — | −3 |
| Q4 2024 | 12 | +1 | 15.63M | $628.72M | +1 | — |
| Q3 2024 | 10 | 0 | 13.10M | $619.83M | +1 | −1 |
| Q2 2024 | 10 | — | 13.21M | $394.27M | — | — |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 6.87M | +3.4% | $276.39M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 6.87M | +3.4% | $276.39M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 3 | Wellington Management ✦ | 5.31M | +14.9% | $213.51M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 4 | Wellington Management ✦ | 5.31M | +14.9% | $213.51M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | Wellington Management ✦ | 5.31M | +14.9% | $213.51M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 6 | Wellington Management ✦ | 5.31M | +14.9% | $213.51M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 7 | Wellington Management ✦ | 5.31M | +14.9% | $213.51M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 8 | Wellington Management ✦ | 5.31M | +14.9% | $213.51M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 9 | Wellington Management ✦ | 5.31M | +14.9% | $213.51M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 10 | State Street Global Advisors ✦ (passiv) | 1.69M | — | $67.94M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Geode Capital Management ✦ (passiv) | 1.11M | +5.0% | $44.48M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 12 | Geode Capital Management ✦ (passiv) | 1.11M | +5.0% | $44.48M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | Two Sigma Investments ✦ | 173.75K | -35.7% | $6.99M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 14 | Soros Fund Management ✦ | 120.37K | Neu | $4.84M | 0.1% | New | 1 | SEC ↗ |
| 15 | Millennium Management ✦ | 115.92K | +205.0% | $4.66M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 16 | Norges Bank ✦ (passiv) | 91.23K | 0.0% | $3.67M | 0.0% | Held | 3 | SEC ↗ |
| 17 | D. E. Shaw & Co. ✦ | 82.58K | -56.1% | $3.32M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 18 | Citadel Advisors ✦ | 58.57K | -4.5% | $2.36M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 19 | Citadel Advisors ✦ | 58.57K | -4.5% | $2.36M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 20 | Marshall Wace ✦ | 6.83K | -94.2% | $274,972 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 6.58K | -46.4% | $264,552 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 6.58K | -46.4% | $264,552 | 0.0% | ▼ Trim | 2 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Soros Fund Management | $4.84M | 0.1% |
Ausgestiegen
| Keine erfassten Ausstiege in diesem Quartal. |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 254 Inhaber, 96.17M Anteile, $7.04B gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.